ONCY Key Stats
- Oncolytics Biotech reports evaluation of clinical study with REOLYSIN Yahoo 04/14 06:49 ET
- Oncolytics Biotech Inc. Collaborators Present Preclinical Research on Liver Cancer at UK Oncolytic Virus Conference CNW Group 04/14 06:45 ET
- Oncolytics Biotech Inc. Collaborators Present Head and Neck Cancer Biomarker Preclinical Research at UK Oncolytic Virus Conference PR Newswire 04/14 06:30 ET
- Oncolytics Biotech Inc. Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference CNW Group 04/11 06:30 ET
- Oncolytics Reports Additional Data on Reolysin - Analyst Blog Zacks 04/09 18:30 ET
- Oncolytics Reports Additional Data on Reolysin Yahoo 04/09 17:30 ET
- Oncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study Yahoo 04/08 06:38 ET
- Oncolytics Biotech (ONCY) Issues Encouraging Update on REO 018 Study Street Insider 04/08 06:32 ET
- Oncolytics Biotech® Inc. Announces Additional Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers CNW Group 04/08 06:30 ET
- Media Advisory - Oncolytics Biotech® Inc. to Participate in 13th Annual Needham Healthcare Conference CNW Group 04/07 07:00 ET
|Mar 13||Earnings||Q4 2013 Oncolytics Biotechâ® Inc. Earnings Results. Estimate: -0.08.|
|Nov 07||Earnings||Oncolytics Biotechâ® Inc. Announces Third Quarter 2013 Results. Estimate: -0.06.|
ONCY Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oncolytics Biotech is down 46.46% over the last year vs S&P 500 Total Return up 23.54%, Alkermes up 48.45%, and Jazz Pharmaceuticals up 148.9%.
Balance Sheet View Statement
Y-Ratings for ONCY
Portfolio Strategies Featuring ONCY
Did Oncolytics Biotech make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Canada
- Headquarters State/Province: Alberta
- Incorporation Country: Canada
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: June 30, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: N/A
- Last Fiscal Year End: N/A
Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.